2025
Oria VO, Castro JL, de Pina Roque J, Martinez AG, Jørgensen FI, Lukassen MV, Rib L, Høg MKG, Mygind KJ, Erler JT. Crosstalk between tumor endothelial cells and cancer cells is important for metastasis initiation. Cell Commun Signal. 2025; 23(1):443.
Righetti M, Primorac AM, Erler JT, Oria VO. Murine Cell Line Models for Vascular Mimicry: The Role of YAP/TAZ Signaling. Int J Mol Sci. 2025; 26(18):9129.
Harsch S, Weber LS, Kassaman D, Kailemia PN, Oria VO. Cancer health literacy in Kenya – A scoping review on evidence, concept and a situational analysis of interventions. Front Public Health. 2025; 13:1527400.
Stagaard R, Jensen A, Schauer T, Bay ML, Tavanez AR, Wielsøe S, Peletier M, Strøbech JE, Oria VO, Zornhagen KW, Albrechtsen R, Christensen JF, Erler JT. Exercise boost after surgery improves survival in model of metastatic breast cancer. Front Immunol. 2025; 16:1533798.
2024
Bryson JW, Uzun Ü, Oria VO, Auxillos JY, Safari I, Lopresti AM, Krzyzanowska A, Sonne-Hansen K. Cultivating the next generation of leaders: How postdocs, principal investigators and institutes can nurture and select for leadership competencies. EMBO Rep. 2024; 25(12):5232-5235. doi: 10.1038/s44319-024-00308-1.
Provance OK, Oria VO, Tran TT, Caulfield JI, Zito CR, Aguirre-Ducler A, Schalper KA, Kluger HM, Jilaveanu LB. Vascular mimicry as a facilitator of melanoma brain metastasis. Cell Mol Life Sci. 2024; 81(1):188.
2023
Oria VO, Erler JT. Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer. Cells. 2023; 12(20):2510.
Piotrowski KB, Blasco LP, Samsøe-Petersen J, Eefsen RL, Illemann M, Oria VO, et al. ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy. Cancer Gene Ther. 2023; 30(10):1369-1381.
Tran TT, Caulfield J, Zhang L, Schoenfeld D, Djureinovic D, Chiang VL, Oria VO, et al. Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma. JCI Insight, 2023 8(7), e157347.
2022
Oria VO, Zhang H, Zito CR, Rane CK, Ma XY, Provance OK, Tran TT, Adeniran A, Kluger Y, Sznol M, Bosenberg MW, Kluger HM, Jilaveanu LB. Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma. Cell Mol Life Sci. 2022 79(7):377.
Lüchtenborg AM, Metzger P, Cosenza Contreras M, Oria VO, et al. Krüppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer. Breast Cancer Res. 2022 24(1):65.
2021
Tran TT, Rane CK, Zito CR, Weiss SA, Jessel S, Lucca L, Lu BY, Oria VO, et al. Clinical significance of PDCD4 in melanoma by subcellular expression and in tumor-associated immune cells. Cancers, 2021; 13(5):1049.
2020
Zhang H, Zhu H, Deng G, Zito CR, Oria VO, et al. PLEKHA5 regulates tumor growth in metastatic melanoma. Cancer, 2020. 126(5):1016-1030.
2019
Behringer S, Wingert V, Oria VO, et al. Targeted metabolic profiling of methionine cycle metabolites and redox thiol pools in mammalian plasma, cells and urine. Metabolites, 2019; 9, 235.
Oria VO, Lopatta P, Schmitz T, Preca BT, Nyström A, et al. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Mol Oncol. 2019; 13 (2), 456-479.
Oria VO, Lopatta P, Schilling O. The pleiotropic roles of ADAM9 in the biology of solid tumors. Cell Mol Life Sci. 2018; 75 (13):2291-2301.
2018
Oria VO, Bronsert P, Thomsen AR, Föll MC, et al. Proteome profiling of primary pancreatic ductal adenocarcinomas undergoing additive chemoradiation link ALDH1A1 to early local recurrence and chemoradiation resistance. Transl Oncol, 2018; 11(6):1307-1322.
Föll MC, Fahrner M, Oria VO, Kühs M, Biniossek ML, et al. Reproducible proteomics sample preparation for single FFPE tissue slices using acid-labile surfactant and direct trypsinization. Clinical Proteomics, 2018; 15 (11).